The results of the long-term follow-up of II9 patients who had DC cardioversion performed are described. All patients had had corrective cardiac surgery for chronic rheumatic valvar heart disease. The poor prognosisfor maintenance of sinus rhythm in this type ofpatient is emphasized. Of the total patients, 83 per cent were converted to sinus rhythm, but relapses were common in those who had atrial fibrillation before operation. Only 40 per cent of such patients maintained sinus rhythm for 2 months, i.5 per cent for I year, and 9 per cent for 2 years.
The commonest indication for elective cardioversion is the presence of atrial fibrillation after cardiac surgery for chronic rheumatic valvar heart disease. Most papers on the follow-up of patients converted to sinus rhythm include conversion from atrial fibrillation due to other causes, where the prospects of maintaining sinus rhythm may differ. This series contains only patients with chronic rheumatic heart disease with atrial fibrillation after corrective cardiac surgery, and also includes those with atrial fibrillation before operation. The trial was designed to determine the effectiveness of conversion to, and maintenance of, sinus rhythm. The period of follow-up is longer than in most other series and extends to 4 years in some patients. The haemodynamic advantages of sinus rhythm are well known, but attempts at restoration of sinus rhythm only seem to be indicated if maintenance of normal rhythm could be expected in a high percentage of patients.
There have been few controlled trials on the long-term use of quinidine to attempt to increase the stability of sinus rhythm after cardioversion, and the results have been confficting. We have, therefore, added the results of our controlled trial of the use of quinidine to maintain sinus rhythm in order to clarify the indications for the use of this potentially dangerous drug.
Patients and methods
One hundred and nineteen patients undergoing attempts at direct current (DC) cardioversion for atrial fibrillation for the first time at Hammersmith Hospital between August I964 and August I968 comprise this series. Only patients with chronic rheumatic heart disease were included. The attempt at cardioversion was made between one month and three months after corrective cardiac surgery. The The number of patients initially in the quinidine group was 43, and in the non-quinidine group, 42.
The type of cardiac surgery that had been performed in the quinidine and the non-quinidine groups is shown in Table 2 .
Results
The number of patients remaining in sinus rhythm at 2 months, i, 2, and 3 years, respectively, for the total series of II9 patients is shown in Fig. i . The results are expressed as the percentage of the patients remaining in sinus rhythm to the total followed up for the appropriate time. The unsuccessful conversions are included in the total number for The results for the two groups, quinidine and non-quinidine patients, are shown in Fig. 2. There were 43 in the quinidine group, and all but 3 were converted to sinus rhythm. There were 42 in the non-quinidine group, one patient died i month after conversion (in sinus rhythm) from post-operative complications, and 7 patients had ceased taking quinidine when seen 2 months after conversion. The latter patients were then added to the nonquinidine group for the purposes of follow-up. In the non-quinidine group 2 patients were lost to follow-up before 2 months. The incidence is only i5 per cent of patients remaining in sinus rhythm at i year. maining in All our patients had chronic rheumatic and nonheart disease, had had corrective cardiac surres of gery performed, and the onset of atrial fibrillation had occurred within the preceding 24 months. rhythm to the Patients were not specifically excluded on propriate time. the basis of a large left atrium though this has ace between the been shown to be prognostically unfavourable ). The over-all (Semer et al., I967) . However, exclusion of ts remaining in patients with atrial fibrillation of longer than iflow-up in both 24 months virtually eliminated all patients he follow-up for with very large atria. The length of follow-up ,e fact that the is longer than in most other series, and it Rgures are ex-appears from our results that there is little ose successfully chance of relapse to atrial fibrillation after al series figures conversion has been maintained for 2 years. ge of all those w-up on those (I965) and by Radford and Evans (I968). Our rial fibrillation findings are in agreement (Fig. 3) Our results show no significant difference in the percentage of patients remaining in sinus rhythm at 2 months, i year, and 2 years, respectively, after conversion, in the quinidine and non-quinidine groups (Fig. 2) . There is also no significant difference in the initial success rate of conversion in either group. The fact that the quinidine group contained io patients with post-operative onset of atrial fibrillation, and the non-quinidine group 14 patients, would only slightly bias the non-quinidine group towards a better prognosis. Furthermore, 41 of the patients in the quinidine group had operations on the mitral valve compared with 33 in the non-quinidine group. This imbalance occurred in spite of our method of random selection into either group. However, since all patients had chronic rheumatic heart disease we have assumed that the prognosis would be similar. This assumption could not be confirmed, however, since the number with aortic valve surgery alone was small and the majority of these patients fell into the group with post-operative onset of atrial fibrillation, which we and others have shown to have a better prognosis for maintenance of sinus rhythm. There were no episodes of sudden death in our patients taking quinidine, but this hazard in a small number of patients is well known (Thomson, I956; Oram and Davies, I964) .
We do not, therefore, recommend the use of quinidine to maintain sinus rhythm after successful conversion of atrial fibrillation to sinus rhythm.
